JK

Juhi Khatoon Mohd Qasim Ansari

Active Director Director DIN 10812777
DIN 10812777 First appointment Oct 2024 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Oct 2024
Shareholding value β€’β€’β€’β€’ Premium profile

About Juhi Khatoon Mohd Qasim Ansari

Data last updated:

Juhi Khatoon Mohd Qasim Ansari is a Director at Mendicare Pharmaceuticals Private Limited (since 2024). The company operates in Pharma.

DIN 10812777
Primary Designation Director
Industry Pharma
First Appointment 18 Oct 2024
Oldest Company Age 2 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director18 Oct 20242024Active

Board colleagues of Juhi Khatoon Mohd Qasim Ansari

NameDINCompanyDesignation
Md Iftekhar Ahmad10812776Mendicare Pharmaceuticals Private LimitedDirector

Directorship timeline

Open interactive timeline →
Mendicare Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Juhi Khatoon Mohd Qasim Ansari

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Juhi Khatoon Mohd Qasim Ansari

Juhi Khatoon Mohd Qasim Ansari currently holds 1 directorship: Mendicare Pharmaceuticals Private Limited (Director, since 18 Oct 2024).

Juhi Khatoon Mohd Qasim Ansari was first appointed on 18 Oct 2024 as Director at Mendicare Pharmaceuticals Private Limited.

The current boards of Juhi Khatoon Mohd Qasim Ansari's companies include Md Iftekhar Ahmad (Mendicare Pharmaceuticals Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available